Gut-brain axis and ADHD
With 100 million neurons, the intestinal nervous system contains about as many as the spinal cord. Both are therefore independent nervous systems.
Most intestinal nervous system neurons are located in:1
- Plexus myentericus Auerbach (in the muscle wall)
- Plexus submucosus Meissner (adjacent to the mucosa).
Specialized neurons of the intestinal nervous system exert an influence within the intestine (promoting or inhibiting depending on the transmitter and receptor):1
- Motor skills (different movement patterns)
- Secretion (water, electrolytes, hormones)
- Perfusion (vascular tone, stimulating (vasodilation) or inhibiting (vasoconstriction) blood flow)
- Resorption
- Signal substance formation
The gut microbiome also has far-reaching interactive effects on the human body:2
- gastrointestinal
- Metabolism
- Nutrient intake
- Carbohydrates
- Proteins
- Bile acid
- Vitamins
- other bioactive compounds
- non-gastrointestinal (especially during the child’s developmental period and then irreversibly, already prenatally through the maternal microbiome)
- Brain development
- Maturation of the immune system
- Maturation of the neuroendocrine system
The enteric nervous system is connected to the body and the brain via the vagus nerve.
Influence vagal afferents:3
- anxiety-like and anxiety-related behavior
- Left-right differentiation and reversal learning
- sensorimotor gating (pre-pulse inhibition)
- Attention control
- for associative learning
- with conditioned taste aversion
- gene expression in the nucleus accumbens
- the effects of L. reuteri on the social behavior of autism mouse models (improvement is prevented by vagotomy)
The gut-brain axis plays a role in brain development, particularly in infancy, early childhood and childhood.4 The mother’s microbiome, the type of birth and the environment influence the child’s microbiome. Breastfeeding and a healthy diet provide the child’s gut with important probiotic elements, while antibiotics can disrupt the intestinal flora. The intestinal flora also influences neurogenesis.4 Microbiota are necessary for normal stress response, anxiety-like behaviors, social behavior and cognition and regulate the homeostasis of the central nervous system via immune function and the integrity of the blood-brain barrier5
Stress can have a significant impact on the gut-brain axis.3
Since microbiota can not only improve but also worsen symptoms / behaviors67 8 9 , it is strongly recommended not to take microbiota without caution. Anything that works can also do harm. In addition, genetic disposition and diet can differentiate between the advantages and disadvantages of an increased or decreased microbiome component. Sometimes the effect of an intestinal bacterium even depends on the strain used.
We find the fact that there are almost no studies reporting a worsening of symptoms or neurophysiological parameters due to the administration of microbiota disconcerting. Since the administration of microbiota resulting in an increase in the relative abundance of one bacterial species is inevitably accompanied by a relative decrease in the abundance of other bacterial species, we see a risk of biased reporting here or that the changes may in fact not be the result of the administration of certain bacterial species, but of an associated other effect, such as a change in the microbiome itself, possibly due to an increase in diversity10
- 1. Gut-brain axis
- 2. What influences the gut-brain axis
- 3. Pathways of the gut microbiome on the brain
- 4. Gut microbiota in ADHD
- 5. Intestinal microbiome and other disorders
1. Gut-brain axis
1.1. Microbiome
Trillions of microorganisms (“microbiota”) live in the human body, which together with their genome are called the “microbiome”. The microbiome is the totality of all bacteria, archaea, fungi, parasites, viruses and protozoa as well as their genes and metabolic products.
The microbiota of the digestive tract comprises more than 100 trillion microorganisms from 300-3000 different species. Together, these have over 200 times as many genes as humans.2
The composition of the microbiome is different for every person and is constantly changing.
1.2. Microbiota / intestinal bacteria
Intestinal bacteria mainly include the six major phyla:2
- Bacteroidetes (dominant)
- Proteobacteria (dominant)
- Actinomycetes
- Verrucomicrobia
- Fusobacteria
Table: Classification of bacteria
The following tabular graphic representation of the systematics of the Kingdom of Bacteria is based on Checa-Ros et al.. (extended)
The illustration shows only a small fraction of the diversity of bacteria.
Phylum | Class | Order | Family | Genus | Species | Strain |
---|---|---|---|---|---|---|
Firmicutes | Bacilli | Lactobacillales | Enterococcaceae | Enterococcus | ||
Lactobacillaceae | Lactobacillus | L. rhamnosus | JB-1 | |||
L. acidophilus | ||||||
L. casei | Shirota | |||||
L. reuteri | 100-23 | |||||
SP-C2-NAJ0070 | ||||||
ATCC-PTA-6475 | ||||||
DSM-17938 | ||||||
L. plantarum | FI8595 | |||||
L. mali | ||||||
L. hildegardii | ||||||
L. johnsonii | MLN-C1-NAJ0142 | |||||
L. helveticus | ROO52 (10(9)cfu/d) | |||||
Negativicutes | Veilonellales | Veilonellaceae | Veilonella | V. parvula | ||
Clostridia | Clostridiales | Ruminicoccaceae | Ruminicoccus | |||
Faecalibacterium | ||||||
Clostridia UCG 014 | ||||||
Clostridia sensu stricto 1 | ||||||
Acetevibrio | ||||||
Lechnospiraceae | Corproccus | |||||
Agathobacter | ||||||
Roseburia | ||||||
Clostridiceae | Clostridium | |||||
Bacteroidetes | Bacteroidia | Bacteroidales | Prevotellaceae | Prevotella | Prevotella amnii | |
Prevotella bucella | ||||||
Prevotella copri | ||||||
Paraprevotella | P. xylaniphila | |||||
Alloprevotella | ||||||
Hallella | ||||||
Porphrymonadaceae | Parabacteroides | |||||
Odoribacter | O. splanchnicus | |||||
Bacteroidaceae | Bacteroides | B. uniformis | ||||
B. ovatus | ||||||
B. coprocola | ||||||
B. thetaiotaomicron | VPI-5482 | |||||
B. fragilis | ||||||
Flavobacteriia | Flavobacteriales | Flavobacteriaceae | ||||
Actinomycetota | Actinomycetes | Bifidobacteriales | Bifidobacteriaceae | Bifidobacterium | B. longum | R0175 |
B. infantis | ||||||
B. breve | ||||||
Coriobacteriales | Coriobacteriaceae | Collinsella | ||||
Proteobacteria | Deltaproteobacteria | Desulfovibrionales | Desulfovibrionaceae | Desulfovibrio | ||
Betaproteobacteria | Burkholderiales | Sutterellaceae | Sutterella | B. stercoricannis | ||
Verrucomicrobia | Verrucomicrobiae | Verrucomicrobiales | Akkermansiaceae | Akkermansia | A. muciniphila | |
Fusobacteria | Fusobacteriia | Fusobacteriales | Fusobacteriaceae |
1.3. Intestinal neurons and nerves connecting to the brain
There are two types of sensory nerves within the intestine:11
- extrinsic primary afferent neurons
The somata of these nerve cells are located outside the intestine
in humans: 50,000 - intrinsic primary afferent neurons (IPANs)
The somata of these nerve cells are located within the intestinal wall
in humans: 100,000,000
Certain bacteria and bacterial components in the intestinal lumen can modulate both the extrinsic and intrinsic intestinal sensory systems and thereby influence peristalsis, nociception, brain chemistry and mood.11
The means of communication used include11
- Serotonin
- Substance P
- Somatostatin
- Cholecystokinin (CCK)
- GABA
- ATP
- Glucagon-like peptide-1 (GLP-1)
- Peptide YY (PYY)
- Hormones
- Leptin
- Orexin
The following microbiota metabolites increased serotonin synthesis in the intestine in vitro:12
- α-Tocopherol
- Butyrate
- Cholate
- Deoxycholate
- p-Aminobenzoate
- Propionate
- Tyramine
1.3.1. Vagus nerve
The communication of the gut-brain axis is bidirectional. The brain influences the motor, sensory and secretory functions of the gastrointestinal tract top-down via efferent fibers of the vagus nerve. The gut influences the function of the brain bottom-up, in particular the amygdala and hypothalamus, via the afferent vagal fibers.13
The afferent fibers of the vagus nerve present in all layers of the intestinal wall do not cross the epithelial layer of the intestine, so that the luminal microbiota cannot interact with them directly. SCFA can cross the epithelial barrier and activate the chemoreceptors of the vagus nerve.14
After stimulation of microbial pattern recognition receptors on their luminal side, enteroendocrine cells also release paracrine factors that can activate the chemoreceptors of the vagus nerve, such as14
- Serotonin (5-HT)
- Cholecystokinin (CCK)
- Glucagon-like peptide-1 (GLP-1)
- Peptide YY (PYY)
In addition, intrinsic primary afferent neurons (IPAN) of the intestinal nervous system (which make up the majority of sensory fibers innervating the intestinal mucosa) could receive microbial signals and subsequently modulate vagal activity via intramural synaptic transmission.14
The vagus nerve has a nicotinic intramural sensory synapse that can receive signals from IPAN. The majority of vagal afferent action potentials elicited by L. rhamnosus depend on this intramural synaptic transmission and can be interrupted by nicotinic or complete synaptic blockade.15
1.3.2. Spinal nerves
In addition to the vagus nerve, spinal nerves also connect the intestinal nervous system with the brain. Spinal afferents are particularly relevant in relation to the microbial modulation of visceral pain perception.11
One of the most important pain receptors in the intestine is the transient receptor potential vanilloid 1 (TRPV1). TRPV1 is expressed in the gastrointestinal tract mainly in spinal and vagal primary afferent neurons. L. reuteri DSM 17938 decreased the firing frequency of nociceptive spinal fibers but not the firing frequency of vagal fibers in the mesenteric nerve bundle. This is probably due to a potent specific direct or indirect blockade of TRPV1 ion channels in extrinsic spinal primary sensory fibers and their corresponding DRG cell bodies. In contrast, the antinociceptive effect of the L. rhamousus JB-1 strain was independent of TRPV1 antagonism.11
1.3.3. Spinal cord
In addition to the vagus nerve and the spinal nerves, the spinal cord also serves as an afferent connection from the intestinal nervous system to the brain.11
2. What influences the gut-brain axis
2.1. Vagotomy
If the vagus nerve, which connects the intestinal nervous system with the brain, is surgically interrupted (vagotomy), this causes behavioral changes:3
- Increase in psychiatric disorders
- neurogenic bowel disorders more common16
- reduced locomotor activity during the dark phase of rodents
- elevated noradrenaline blood plasma levels
- basal
- after immobilization stress
- reduced proliferation and survival of newborn cells, reduced number of immature neurons
- Activation of microglia in the dentate gyrus of the hippocampus
In the case of Salmonella typhimurium-induced enteritis, which causes anxiety-like behavior, a unilateral cervical vagotomy17
- reduced anxiety-like behavior
- reduced neuronal activation in the nucleus of the tractus solitaire and in the amygdala
- Attenuation of abnormal glial cell activation in the hippocampus and amygdala
- reduced serum endotoxin levels
- Increase in Salmonella concentration in the spleen reduced
- altered expression of inflammatory cytokines (including IL-6, IL-1β and TNF-α) in the gastrointestinal tract and brain
- reduced expression of IL-22 and CXCL1
- increased levels of beneficial intestinal microbiota (including Alistipes and Lactobacillus)
- increased GABA synthesis in the intestine
- Administration of GABA replicated the positive effects of vagotomy on reducing intestinal inflammation and anxiety-like behavior in infected mice
- Blockade of GABA receptors by picrotoxin abolished the protective effect of vagotomy against intestinal inflammation without affecting anxiety-like behavior
2.2. Antibiotics
Antibiotics change the intestinal microbiota. They influence their effects on the brain not only in children, but also in adults.18
Oral administration of the antibiotics neomycin and bacitracin together with the antifungal agent primaricin in adult BALB/c mice19
- temporary change in the composition of the intestinal microbiota
- increased urge to explore
- reduced anxiety
- BDNF mirror
- reduced in amygdala
- increased in the hippocampus
- Fecal transplantation into another mouse strain caused similar behavioral changes in this strain
Mice that were continuously treated with an antibiotic cocktail from weaning (postnatal day 21) showed:20
- impoverished and restructured intestinal microbiota
- less anxiety-like behavior
- fewer cognitive deficits
- increased tryptophan and reduced kynurenine levels in serum
- reduced expression of BDNF, oxytocin and vasopressin in the brain
An administration of the antibiotic vancomycin in the early phase of life (4th to 13th postnatal day) in rats showed that21
- fear-like behavior unchanged
- cognitive performance unchanged
- long-term increase in visceral hypersensitivity only in males
- reduced alpha-2-adrenoceptors and TRPV1 in the lumbo-sacral section of the spinal cord in adulthood
Rifaximin prevented chronic stress-induced visceral hypersensitivity, mucosal inflammation and impaired mucosal barrier function in rats22
- this correlated with an increase in Lactobacillus in the ileum
Neomycin, on the other hand, did not prevent visceral hypersensitivity22
2.3. Vagus nerve stimulation
Vagus nerve stimulation is approved in Europe for the treatment of drug-resistant epilepsy and refractory depression.
For vagus nerve stimulation, electrodes are surgically implanted under general anesthesia on the left vagus nerve and a generator and cable are implanted under the skin.
Vagus nerve stimulation influences / works for:3
- the regulation of mood
- the perception of pain (chronic pain)
- Crohn’s disease
- certain epilepsies
- increases neurogenesis in the hippocampus of adults
- modulates the release of noradrenaline, 5-HT and dopamine in brain regions associated with anxiety and depression
- increases the expression of BDNF in the hippocampus, which improved depression-like behaviors in animals with chronic immobilization stress
- influences the reward behavior of mice
2.4. Food
High-energy food seems to promote reactive aggressive behavior in combination with certain bacterial strains on the one hand and with ADHD on the other.23
2.5. Short-chain fatty acids, SCFA
The primary functions of the microbiota include24
- Protection against pathogens by increasing mucus production and thus stabilizing the intestinal-blood barrier
- Support for the immune system
- Production of vitamins
- Production of short-chain fatty acids (SCFAs) from indigestible carbohydrates (“dietary fiber”).
A low-fiber diet reduces SCFA levels, as do antibiotics.
SCFA can activate the chemoreceptors of the vagus nerve. The afferent fibers of the vagus nerve present in all layers of the intestinal wall do not cross the epithelial layer of the intestine, so that the luminal microbiota cannot interact with them directly. SCFA can cross the epithelial barrier.14
Short-chain fatty acids are:
Abbreviation of the fatty acid | Trivial name | Systemic name | Trivial name salt/ester | Systemic name salt/ester | Chemical formula | Typical plasma value25 |
---|---|---|---|---|---|---|
C1:0 (no SCFA) | Formic acid | Methanoic acid | Formates | Methanoates | HCOOH | |
C2:0 | Acetic acid | Ethanoic acid | Acetates | Ethanoates | CH3COOH | 64 μM |
C3:0 | Propionic acid | Propanoic acid | Propionates | Propanoates | CH3CH2COOH | 2.2 μM |
C4:0 | Butyric acid | Butanoic acid | Butyrate | Butanoate | CH3(CH2)2COOH | 0.54 μM |
C4:0 | Isobutyric acid | 2-Methylpropanoic acid | Isobutyrate | 2-Methylpropanoate | (CH3)2CHCOOH | 0.66 μM |
C5:0 | Valeric acid | Pentanoic acid | Valerate | Pentanoate | CH3(CH2)3COOH | 0.18 μM |
C5:0 | Isovaleric acid | 3-Methylbutanoic acid | Isovalerate | 3-Methylbutanoate | (CH3)2CHCH2COOH | 0.40 μM |
C6:0 | Caproic acid | Hexanoic acid | Capronate | Hexanoate | CH3(CH2)4COOH | 0.34 μM |
In humans, acetates, propionates and butyrates make up 95% of SCFA, in a ratio of 3:1:1.3 A more recent study found other and more detailed differences, which are shown in the table above25
SCFAs corrected the changes that chronic psychosocial stress caused in the gut-brain axis.26 SCFAs
- mitigated the changes in reward behavior triggered by psychosocial stress
- increased the ability to react to an acute stressor
- increased the in vivo intestinal permeability
- had an antidepressant effect
- had an anxiolytic effect
- did not influence the stress-related increase in body weight
2.6. Probiotics
There is evidence that when prebiotics are administered, an effect (in the brain) only occurs after several weeks, comparable to the effect of antidepressants.27 Several weeks after discontinuation, some, but not all, neurotransmitter levels in the brain had returned to their original value.
2.7. Fecal transplantation
Rodents raised germ-free have:11
- an altered brain chemistry
- increased permeability of the blood-brain barrier
- an underdeveloped intestinal nervous system (ENS)
- reduced peripheral 5-HT production
- altered intestinal motility and physiology
- numerous deficits of the immune system.
Nevertheless, they are particularly suitable for investigating the effects of fecal transplants and have shown that the transfer of gut microbiota into germ-free animals can transfer behavioral traits of the donor animals.11
2.8. Intestinal flora and stress
Microbiota are necessary for normal stress response, anxiety-like behaviors, social behavior and cognition and regulate central nervous system homeostasis via immune function and blood-brain barrier integrity5
The vagus nerve and HPA axis influence each other.
Vagal nerve stimulation3
- increased the expression of CRF mRNA in the hypothalamus of rodents
- markedly increased the plasma levels of ACTH and corticosterone
In animal models, psychological stress increased the permeability of the intestine and caused a relocation of intestinal bacteria into the host. The activation of the immune response due to exposure to bacteria and bacterial antigens beyond the epithelial barrier causes proinflammatory cytokine secretion and ultimately activates the HPA axis.28
The gut microbiome is essential for the development and function of the HPA axis (stress axis).292
Germ-free reared mice show an exaggerated HPA axis response and reduced sensitivity to negative feedback signals. Bifidobacterium infantis given early reversed this response.2
Early childhood stress influences the microbiome.30
3. Pathways of the gut microbiome on the brain
Intestinal bacteria (intestinal microbiome, intestinal flora) influence the nervous system via various mechanisms.31
3.1. Metabolic / neuroendocrine pathway
Metabolic / neuroendocrine pathway:132
3.1.1. Modulation of neurotransmitters by the microbiome
The microbiome modulates neurotransmitters31 such as GABA, serotonin, dopamine, noradrenaline13
- direct synthesis2
- indirectly via biosynthetic pathways of the host organism
- Synthesis of precursors of neurotransmitters (e.g. for dopamine)2
- by secretion of short-chain fatty acids (SCFAs)13. These:
- activate microglial cells32
- influence the permeability of the blood-brain barrier33
- Suppression of the synthesis of the pro-inflammatory TNF by converting L-histidine into the immunoregulatory histamine (L. reuteri)34
Bacteria can synthesize neurotransmitters and hormones and react to them:13
Table: Bacteria and neurotransmitter synthesis
Bacterium | Dopamine (DA) | Noradrenaline (NE) | Serotonin (5-HT) | GABA | Acetylcholine (ACh) | Histamine (Hist) | Other influences |
---|---|---|---|---|---|---|---|
Bacillus species | produce DA3536 | produce NE3536 | |||||
Bacillus cereus | produce DA31 | ||||||
Bacillus mycoides | produce DA31 | produce NE31 | |||||
Bacillus subtilis | produce DA31 | produce NE31 | |||||
Bifidobacterium species | produce precursors of dopamine2 | produce GABA3536 | |||||
Bifidobacterium adolescentis | produce GABA31 | ||||||
Bifidobacterium angulatum | produce GABA31 | ||||||
Bifidobacterium dentium | produce GABA31 | ||||||
Bifidobacterium infantis | produce GABA31 | ||||||
Candida | produce 5-HT36 | ||||||
Cirobacter freundii | produce Hist31 | ||||||
Enterobacter spp. | produce Hist31 | ||||||
Enterococcus | convert L-dopa into DA37 | produce 5-HT3536 | |||||
Escherichia | produce DA3135 36 | produce NE3631 | produce 5-HT3638 31 | ||||
Hafnia alvei (NCIMB, 11999) | produce DA31 | produce 5-HT3831 | produce Hist31 | ||||
Klebsiella pneumoniae (NCIMB, 673) | produce DA31 | produce 5-HT3831 | produce Hist31 | ||||
L. lactis subsp. lactis (IL1403) | produce 5-HT38 | ||||||
Lactobacillus species | produce GABA3536 | produce ACh3536 | |||||
Lactobacillus brevis (DPC6108) | produce GABA31 | ||||||
Lactobacillus buchneri (MS) | produce GABA31 | ||||||
Lactobacillus delbrueckiisubsp. bulgaricus (PR1) | produce GABA31 | ||||||
Lactobacillus hilgardii | produce Hist31 | ||||||
Lactobacillus mali | produce Hist31 | ||||||
Lactobacillus plantarum (FI8595) | produce 5-HT3831 | (ATCC14917) produce GABA31 | produce ACh31 | produce Hist31 | |||
Lactobacillus reuteri (100-23) | produce GABA31 | ||||||
Lactobacillus rhamnosus (JB-1) | produce GABA31; for GABA receptors see * | see ** | |||||
Lactococcus lactis subsp. cremoris (MG 1363) | produce 5-HT3831 | produce Hist31 | |||||
Lactococcus lactis subsp. lactis (IL1403) | produce Hist31 | ||||||
Monasmus purpureus (CCRC 31615) | produce GABA31 | ||||||
Morganella morganii (NCIMB, 10466) | produce DA31 | produce 5-HT3831 | produce Hist31 | ||||
Oenococcus oeni | produce Hist31 | ||||||
Pediococcus parvulus | produce Hist31 | ||||||
Proteus vulgaris | produce DA31 | produce NE31 | |||||
Saccharomyces | produce NE36 | ||||||
Serratia | produce DA36 | ||||||
Serratia marcescens | produce DA31 | produce NE31 | |||||
Staphylococcus aureus | produce DA31 | ||||||
Streptococcus | produce 5-HT3536 | ||||||
Streptococcus thermophilus (NCFB2392) | produce 5-HT3831 | produce Hist31 | |||||
Streptococcus salivarius subsp. thermophilus (Y2) | produce GABA31 | ||||||
* Altered the expression of GABA receptors in the brain via the vagus nerve39; GABA-B1b receptor mRNA increased in the cortex (cingulate and prelimbic), decreased in the hippocampus, amygdala and locus coeruleus, GABA-Aα2 mRNA reduced in the PFC and amygdala, increased in the hippocampus.
** Reduced stress-related corticosterone secretion39; reduced anxiety- and depression-related behavior39
The production of dopamine, noradrenaline and serotonin in intestinal neurons does not mean that the neurotransmitters synthesized in this way reach the brain.
- Blood-brain barrier
Acetylcholine can cross the blood-brain barrier. However, dopamine, noradrenaline, serotonin and GABA cannot, which means that these latter neurotransmitters produced in the gut do not directly change the levels in the brain. - extracellular vesicles (EV) can cross the blood-brain barrier
Intestinal microbiota - like other bacteria - produce extracellular vesicles (EV).40 If these originate from gram-negative bacteria, EV are called “outer membrane vesicles (OMV)”.41
These nano-sized EVs (20 to 1000 nm) can penetrate the inner mucus layer, enter the bloodstream and cross the blood-brain barrier to the brain.424344454647
95 % of serotonin is produced by enterochromaffin cells in the intestine, 5 % in the brain. Akkermansia muciniphila, which makes up around 5 % of intestinal bacteria and in which a deficiency correlates with various chronic inflammatory bowel diseases such as colitis and Crohn’s disease, influenced serotonin levels in the hippocampus of mice via its EVs.42 Another study shows that extracellular vesicles of Escheria coli enter the hippocampus.48 - Axonal transport
We wonder whether neurotransmitters synthesized in the gut could be transported to the brain via the vagus nerve. So far there is no evidence for this. However, there is evidence that nerve fibers of the vagus nerve contain dopamine.49 Furthermore, peripheral nerves such as the vagus nerve can transport nanoparticles into the brain.50 Synuclein can also be transported from the body into the brain via nerves, which may be of interest with regard to the development of Parkinson’s disease.51 In cohort studies, a truncal vagotomy showed a significant protective effect against Parkinson’s disease.5253 - Influencing the prodrug balance
Intestinal bacteria influence the blood levels of the precursors of dopamine, noradrenaline, serotonin and GABA, which can cross the blood-brain barrier. Consequences are that the blood level of the precursors could influence the amount of neurotransmitters synthesized from them in the brain. For example, a slight increase in Bifidobacterium in the gut, as found in ADHD, is associated with increased production of cyclohexadienyl dehydratase, which is a precursor to phenylanaline, which is a precursor to dopamine. At the same time, the increase in Bifidobacterium is thought to be associated with reduced reward anticipation, suggesting reduced dopamine levels in the striatum.54 How these two seemingly contradictory pathways fit together is not yet clear to us.
3.1.2. Immune system pathway and microbiome
The microbiome influences the immune system via circulating cytokines.132
3.2. HPA axis is influenced by the microbiome
The microbiome influences HPA axis activity. Germ-free (without mirobiota) mice have an overactivated HPA axis with an increased release of stress hormones such as corticosterone and ACTH during restraint stress.55
3.3. Nerve pathway of the microbiome
The microbiome influences the brain via the neural pathway.2
- by stimulation of the vagus nerve:135639
- The vagus nerve has 80 % afferent fibers, which transmit sensory stimuli from the body to the brain, and 20 % efferent fibers, which transport motor signals from the brain to the body.1
- by means of the enteric nervous system2
3.4. Epigenetics and the microbiome
Influence on epigenetic processes in the brain (neuroepigenetic)57
- e.g. through SCFA (short-chain fatty acids); these influence
- Acetylation and butyrylation of histone proteins58
- facilitates binding of transcription factors to DNA and thus transcription of genes
- post-translational modification of histones (crotonylation, butyrylation)596061
- Neuroplasticity (e.g. in the visual cortex of adult mice)62
- Gene expression in cortical astrocytes63
- Acetylation and butyrylation of histone proteins58
- DNA methylation57
- Changes in DNA methylation occur during learning and memory consolidation
- the one-carbon metabolic pathway64 of DNA methylation is regulated by the availability of cofactors. Some of these (such as cobalamin, folate, pyridoxine and riboflavin) are metabolic products of intestinal bacteria
- The gut microbiome influences DNA methylation in intestinal epithelial cells
- Influence of the gut microbiome on DNA methylation and transcription in the brain has not yet been proven.
3.5. MiRNA (microRNA) and microbiome
Lack of gut microbiota correlates with changes in the expression of various miRNAs, particularly in the amygdala and PFC.57
miRNA regulate e.g: 57
- the dendritic morphology
- the spine density in the neurons of the hippocampus
- visual cortical plasticity (by influencing spine remodeling)
- cortical plasticity
4. Gut microbiota in ADHD
4.1. Gut bacteria as a possible causal cause of ADHD?
One study found evidence of a causal relationship between gut bacteria and ADHD.65 (Note: Even if causality were confirmed, it should be assumed that this represents only one of many different possible ways in which ADHD can develop and would therefore not apply to all people with ADHD)
One study found that mice whose guts were contaminated with gut bacteria from people with ADHD had structural changes in the brain (white matter, gray matter, hippocampus, internal capsule), decreased connectivity between motor and visual cortices right in the resting state, and higher anxiety than mice in which gut bacteria from people without ADHD were used.66
A single case study reported an improvement in ADHD symptoms in a young woman with gut bacteria replacement related to a recurrent Clostridioides difficile infection.67
Taxonomic differences were found in the microbiota of adolescents and young adults with ADHD compared to healthy controls:54
- An abundance of actinobacteria was found in persons with ADHD
- the capacity of the intestinal microbiome to produce monoamine precursors (phenylalanine) was increased
- the abundance of cyclohexadienyl dehydratase (CDT) genes in the microbiome involved in phenylalanine production correlated negatively with reward anticipation responses in the ventral striatum (with ventral striatum activation for reward anticipation reduced in ADHD)
A study of urine and fecal samples using 1H nuclear magnetic resonance spectroscopy and liquid chromatography-mass spectrometry found gender-specific patterns in the metabolic phenotype in ADHD68
- Urine profile
- Hippurate (a product of microbial host co-metabolism that can cross the blood-brain barrier)
- increased (men only)
- correlated negatively with IQ (in men)
- correlated with fecal metabolites associated with microbial metabolism in the gut.
- Hippurate (a product of microbial host co-metabolism that can cross the blood-brain barrier)
- Fecal profile (independent of ADHD medication, age and BMI)
- Stearoyl-linoleoyl-glycerol increased
- 3,7-Dimethylurate increased
- FAD increased
- Glycerol-3-phosphate reduced
- Thymine reduced
- 2(1H)-quinolinone reduced
- Aspartate reduced
- Xanthine reduces
- Hypoxanthine reduces
- Orotate reduced
Gut microbiome and dopamine
- The gut microbiome influences dopamine levels in the PFC and striatum of rodents2
- A slight increase in Bifidobacterium in the gut, as found in ADHD, is thought to be associated with increased production of cyclohexadienyl dehydratase, which is a precursor to phenylanaline, which is a precursor to dopamine. At the same time, the increase in Bifidobacterium is thought to be associated with reduced reward anticipation, suggesting reduced dopamine levels in the striatum.54 How these two seemingly contradictory pathways fit together is not yet clear to us.
- Gut microbiome composition correlates with impulsivity, increased striatal D1R and decreased D2R with increasing susceptibility to alcohol dependence69
- Intestinal inflammation can impair the dopamine metabolism70
- An infection with Citrobacter rodentium triggers an inflammatory bowel disease in mice. This affected not only the intestinal microbiota but also the brain dopamine metabolism. An additional administration of MPTP (a precursor of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+), which can trigger Parkinson’s symptoms by damaging dopaminergic neurons) compared to the administration of Citrobacter rodentium or MPTP alone:
- worsened behavioral performance
- increased dopaminergic degeneration and overactivation of glial cells in the nigrostriatal signaling pathway
- increased the expression of TLR4 and NF-κB p65 in the colon and striatum
- increased the expression of pro-inflammatory cytokines.
- An infection with Citrobacter rodentium triggers an inflammatory bowel disease in mice. This affected not only the intestinal microbiota but also the brain dopamine metabolism. An additional administration of MPTP (a precursor of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+), which can trigger Parkinson’s symptoms by damaging dopaminergic neurons) compared to the administration of Citrobacter rodentium or MPTP alone:
4.2. Microbiome and short-chain fatty acids (SCFA) in ADHD
Studies on short-chain fatty acids found reduced SCFA blood levels in ADHD:7172
- Adults with ADHD
- Formic acid reduces
- Acetic acid reduces
- Propionic acid reduces
- Succinic acid reduced (C4H6O, an aliphatic dicarboxylic acid; food additive number E 363)
- Children with ADHD
- Formic acid lower than in adults
- Propionic acid lower than in adults
- Isovaleric acid lower than in adults
- Antibiotic medication in the last 2 years caused
- Formic acid reduces
- Propionic acid reduces
- Succinic acid reduces
- current stimulant use in children caused
- Acetic acid reduces
- Propionic acid reduces
4.3. Gut microbiota differences in ADHD
Studies have found deviations in the intestinal flora of children with ADHD compared to those not affected.24 In contrast, the intestinal flora differs only slightly between ADHD and ASD.73
ADHD correlated with leaky gut, neuroinflammation and overactivated microglial cells. The colonic microbiota exhibits a pro-inflammatory shift and harbors more gram-negative bacteria that contain immune-triggering lipopolysaccharides in their cell walls.74
Disorders of the developing gut microbiota early in life can affect neurological development and potentially lead to adverse mental health outcomes later in life.75
75 infants were randomly assigned to receive either Lactobacillus rhamnosus GG or a placebo in the first 6 months of life. After 13 years, ADHD or ASD was found in 17% of the placebo group and none in the probiotic group. Bifidobacteria in the intestinal microbiome of the children with ADHD were significantly reduced in the first 6 months of life.7677
It is known that caesarean section compared to vaginal birth and bottle feeding compared to breastfeeding (especially in the first three months) changes the composition of the infant’s microbiome and increases the risk of ADHD. More on this at Caesarean section In the chapter Birth circumstances as a cause of ADHD and Bottle feeding increases (up to + 270 %), breastfeeding reduces ADHD risk (- 23 % to -74 %) in the chapter Stressful physical or emotional childhood experiences as a cause of ADHD
4.3.1. Reduced intestinal bacteria in ADHD
List of reduced gut bacteria in ADHD
- Alistipes finegoldii (species)78
- Alistipes indistinctus (species)78
- Bacillales noname (family)78
- Bacteroidetes (Phylum)79
- Bacteroides coprocola (species)80
- Bacteroides cellulosilyticus (species)78
- Bacteroides fluxus (species)78
- Bacteroides fragilis (species)78
- Bacteroides intestinalis (species)78
- Bacteroides nordii (species)78
- Bacteroides salyersiae (species)78
- Bacteroides thetaiotaomicron (species)78
- Bacteroides ovatus (species)78
- Bifidobacterium
- Butyricicoccus65
- Clostridia_UCG_014 (meta-analysis, k = 4, n = 627) (genus)81
- Desulfovibrio65
- Dial register8279
- Dialister level increased after ADHD treatment
- Enterobacter83
- Enterococcus84
- Convert L-dopa into dopamine37 Since L-dopa, but not dopamine, can cross the blood-brain barrier, a reduction of enterococcus in the gut should lead to more L-dopa in the brain, where it would be available as a precursor for dopamine. How this interacts is not yet clear to us.
- Eubacterium
- Eubacterium hallii (species)83
- Eubacterium_xylanophilum_Group (meta-analysis, k = 4, n = 627)81
- Enterococcus84
- Faecalibacterium (strain Firmicutes, class Flavobacteria)858684
- Faecalibacterium prausnitzii (also known as Faecalibacterium duncaniae) (Species)8879
- anti-inflammatory74
- Flavobacteriia (class)78
- Fusobacteria (Phylum)78
- Gemella (genus)78
- Haemophilus79
- Lachnoclostridium79
- LachnospiraceaeNC2004group65
- Lachnospiraceae bacterium88
4.3.2. Increased intestinal bacteria in ADHD
List of elevated gut bacteria in ADHD
- Agathobacter92
- correlated with withdrawal symptoms and depression
- Alloprevotella83
- Bacillota (synonym: Firmicutes)93
- Bacteroidaceae94
- Bacteroidetes93
- Bacteroides93
- Correlated with hyperactivity / impulsivity in ADHD87
- Bacteroides uniformis (B. uniformis) (Species)80
- Bacteroides ovatus (B. ovatus) (Species)
- Increase correlated with ADHD symptoms80
- Bacteroides caccae88
- Bacteroides faecis (OR: 1.09)95
- Bacteroides eggerthii correlated with PTSD (OR: 1.11), not with ADHD95
- Bacteroides thetaiotaomicron correlated with PTSD (OR: 1.11), not with ADHD95
- Bacteroides93
- Bacteroidota93
- Bifidobacterium79 (strain: Actinobacterium)
- Anti-inflammatory74
- Increases54
- A slight increase in Bifidobacterium in the gut is thought to be associated with increased production of cyclohexadienyl dehydratase, which is a precursor to phenylalanine, which is a precursor to dopamine. At the same time, the increase in Bifidobacterium is thought to be associated with reduced reward anticipation, suggesting reduced dopamine levels in the striatum.54 How these two seemingly contradictory pathways fit together is not yet clear to us.
- Bifidobacterium encodes the enzyme arenate dehydratase (ADT), which is important for the production of phenylalanine. Phenylalanine can cross the blood-brain barrier and is a precursor of tyrosine, which is required for DA and NE synthesis.96 However, a small study found no systematic phenylalanine or tyrosine abnormalities in children with ADHD.97
- Bifidobacterium breve (species)78
- Bifidobacterium bifidum (species)78
- Clostridiales (order)9899
- Desulfovibrio (genus)98
- Eisenbergiella (meta-analysis, k = 4, n = 627)81
- Eggerthella8679
- Enterococcus79
- Eubacterium hallii group65
- Flavonifractor
- Pro-inflammatory74
- Fusobacterium79
- Lachnospiraceae99
- Lactobacillus mucosae (species)78
- Neisseriaceae94
- Odoribacter79 (Metastuie, k = 2)86
- Paraprevotella79
- Paraprevotella xylaniphila (Species)84
- Proteobacteria (Phylum)92
- Roseburia6592 79
- anti-inflammatory74
- Ruminococcaceae99
- Ruminococcus gnavus (Species)92
- correlated with rule-breaking behavior
- Ruminococcus gnavus (Species)92
4.3.3. Alpha diversity
Study results on the alpha diversity of the gut microbiota in ADHD are inconsistent.
The majority of studies do not appear to show increased alpha diversity.
We will collect study results on this topic here.
Meta-analyses, reviews:
- A meta-analysis (k = 4, n = 619 adults) found no change in alpha diversity in ADHD.81
- unchanged alpha diversity100
Studies:
- significantly lower α-diversity (Shannon index, observed species, Faith PD index)101
- unchanged alpha diversity78102 84 85
- in mice with ADHD66
4.3.4. Beta diversity
Study results on beta diversity of the gut microbiota in ADHD are inconsistent.
The majority of studies do not appear to show increased beta diversity.
We will collect study results on this topic here.
Meta-analyses, reviews:
- A meta-analysis (k = 4, n = 619 adults) found a significant correlation between beta diversity and ADHD in 3 of the 4 studies.81
- no deviating beta diversity100
Studies:
- A study on n = 73 subjects found a trend towards the significance of β-diversity (weighted UniFrac).103
- no relevant change in beta diversity102
- altered beta diversity in ADHD-C, but not in ADHD-C78
- increased beta diversity in mice with ADHD66
4.3.5. Gut microbiota similar in ADHD and ASD
The gut microbiota in ADHD and ASD are quite similar in both alpha and beta diversity and differ significantly from non-affected individuals.
In addition, a subgroup of ADHD and ASD cases had increased levels of lipopolysaccharide-binding protein, which positively correlated with interleukin IL-8, IL-12 and IL-13, compared to non-affected children. This suggests an intestinal barrier disorder and immune system dysregulation in a subgroup of children with ADHD or ASD.104
Germ-free mice that received a fecal transplant from persons with ADHD subsequently showed105
- characteristic autistic behaviors
- alternative splicing of ASD-relevant genes in the brain
When ASD model mice received appropriate microbial metabolites, this improved the behavioral abnormalities and modulated neuronal excitability in the brain.105
4.3.6. Urinary microbiota in ADHD
A study of the urinary microbiome in ADHD found:106
- a lower alpha diversity in the urine bacteria of the ADHD group
- reduced Shannon and Simpson indices (p < 0.05)
- significant differences in beta diversity
- were common with ADHD:
- Phyla Firmicutes
- Actinobacteriota
- Ralstonia (genus)
- Afipia (genus)
- less frequently with ADHD:
- Phylum Proteobacteria
- Corynebacterium (genus)
- Peptoniphilus (genus)
- Afipia correlated significantly with the Child Behavior Checklist Attention Problems score and the DSM-oriented ADHD subscale
5. Intestinal microbiome and other disorders
5.1. Microbiota against anxiety / depression
5.1.1. Studies on rodents
Lacticaseibacillus rhamnosus JB-1 (Lactobacillus rhamnosus) caused
- only in non-vagotomized mice:39
- GABA(B1b) mRNA
- increased expression in the ACC and prelimbic cortex
- reduced expression in the hippocampus, amygdala and locus coeruleus
- GABA(Aα2) mRNA
- increased in the hippocampus
- reduced in the amygdala
- Corticosterone stress response reduced
- Reduced anxiety behavior
- Depressive behavior reduced
- GABA(B1b) mRNA
- prevented the behavioral changes caused by chronic unpredictable mild stress in rats107
- reduces anxiety-like behavior
- depression-like behavior reduced
- Decrease in glutamine and glutathione levels in the hippocampus avoided
- Decreases in taurine in the hippocampus.
Acute and chronic administration of the short-chain fatty acid sodium butyrate in addition to fluoxetine significantly reduced immobility values in mice in the tail suspension test by 20-40% compared to administration of only one of the two drugs108
Injection of sodium butyrate caused
- short-term histone hyperacetylation in the hippocampus and in the PFC
- a transient, at least 50% increase in the BDNF transcript in the PFC
5.1.2. Studies on humans
Daily administration of a combination of L. helveticus and B. longum in a double-blind, randomized, placebo-controlled study in healthy women and men reduced perceived stress, anxiety and depression levels and 24-hour urinary cortisol levels slightly but statistically significantly.109
Daily administration of Lactobacillus casei Shirota in a double-blind, randomized, placebo-controlled study in patients with chronic fatigue significantly reduced anxiety symptoms, but not depressive symptoms.110
5.2. Microbiota against ASS
5.2.1. Studies on rodents
Fructo-oligosaccharides and galacto-oligosaccharides reduced chronic stress-induced social avoidance, cognitive dysfunction, anhedonia, HPA axis hyperreactivity, and anxiety- and depression-like behavior in mice.111
Limosilactobacillus reuteri administration caused
- only in non-vagotomized mice
- Change in social behavior in autism mouse model3
- Improvement of social behavior in different autism mouse models112
- via the vagus nerve and oxytocinergic and dopaminergic signaling in the brain
- not by restoring the composition of the gut microbiome per se
- by induction of synaptic plasticity in the VTA of ASA mice
- by (via L. reuteri) increased oxytocin113114 in various ASA mouse models:
- genetic ASD mouse models
- Shank3B-/-115112
- Cntnap2-/-116
- L. reuteri levels are reduced in Cntnap2-/- mice
- L. reuteri remedied the deficits of the oxytocin-producing neurons
- L. reuteri corrected the social deficits in both young and adult Cntnap2-/- (KO-I) mice
- L. reuteri did not eliminate the hyperactivity typical of Cntnap2-/- mice
- environmental ASS mouse models
- idiopathic ASD mouse model (BTBR)112
- genetic ASD mouse models
- not in mice with missing or blocked oxytocin receptors in dopaminergic neurons
- by (via L. reuteri) increased oxytocin113114 in various ASA mouse models:
- via the vagus nerve and oxytocinergic and dopaminergic signaling in the brain
In another study, ASA also correlated with reduced plasticity in the VTA, which was caused by a high-fat diet in the mother. The ASA behavior was transferred from the offspring to germ-free mice.113
In a preclinical ASD mouse model, only L. reuteri strain ATCC-PTA-6475, but not strain DSM-17938, improved social deficits.118
A study on Cntnap2-/- and Cntnap2+/+ mice found that both mouse lines showed the hyperactivity known from this ASD mouse model. In the Cntnap2+/+, however, social behavior was normalized, as was the microbiome. This also indicates that the ASD-typical changes in social behavior are caused by the microbiome 116
The study results with regard to L. reuteri in ASD are impressive. The question mentioned by and in the introduction as to which part of the improvement is due to the administration of specific biota (here: L. reuteri) and which is due to the increase in the diversity of the microbiome through the administration of microbiota should have little relevance here. The argument that people with ADHD could have impaired intestinal flora diversity due to restricted food preferences is certainly worth considering, but should only apply to humans and not to mice. In any case, selective feeding habits of ASD model mice have not been reported so far.
The same applies to possible influences on the oral bacterial flora due to sensory stress, which makes tooth cleaning more difficult.119
B. fragilis improves deficits in communicative, stereotypic, anxiety-like and sensorimotor behavior in an ASD mouse model in which ASD was caused by prenatal virus administration. It also corrected intestinal permeability and altered the microbiome composition.120
5.2.2. Studies on humans
A double-blind, randomized, placebo-controlled study on the effect of L. reuteri in children with ASD found:118
- significantly improved social functioning across various metrics
- no change from
- ASA overall severity
- repetitive behaviors
- Microbiome composition
- Immune profile
A study on children with ASD reports a positive effect of an elimination diet on gastrointestinal complaints and a prebiotic on social behavior.121
5.3. Microbiota and multiple sclerosis
In one study, Limosilactobacillus reuteri improved the severity of experimental autoimmune encephalomyelitis in mice, which serves as a model for multiple sclerosis, indicating a deficiency of L. reuteri in MS.8 In contrast, two other studies found an excess of L. reuteri as a risk factor for MS.89
It is possible that the gut microbiota and diet could act synergistically in people genetically susceptible to MS, with diet-dependent gut microbial metabolites serving as a key mechanism for the disease. Due to these gene-gut microbiota interactions, specific microbial taxa could have different effects depending on MS risk alleles or other gene polymorphisms, which are also highly dependent on dietary intake. This could explain why results differ across geographic, dietary and genetic conditions. Prophylactic or therapeutic modulation of the gut microbiome to prevent or treat MS would therefore require careful and personalized consideration of genetic makeup, gut microbiota composition and dietary habits.122 This is consistent with the ability of L. helveticus to attenuate anxiety-like behavior in mice only as a function of genotype diet.123
Applied to other disorders, contradictory results of effects of certain microbiota on certain symptoms should be regarded as a warning against careless testing of the effect on individuals.
5.4. Mirobiota and systemic lupus erythematosus (SLE)
In the Toll-like receptor 7 (TLR7) mouse model of systemic lupus erythematosus (SLE), L. reuteri increased autoimmune manifestations under specific-pathogenic and gnotobiotic conditions, particularly through an increase in plasmacytoid dendritic cells and interferon signaling. The incidence and translocation of L. reuteri to other organs could be reduced by resistant starch in the diet using SCFA. Resistant starch also reduced plasmacytoid dendritic cells, interferon signaling and mortality.124
Checa-Ros A, Jeréz-Calero A, Molina-Carballo A, Campoy C, Muñoz-Hoyos A (2021): Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications. Nutrients. 2021 Jan 16;13(1):249. doi: 10.3390/nu13010249. PMID: 33467150; PMCID: PMC7830868. REVIEW ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Cryan JF, O’Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE, Jaggar M, Long-Smith CM, Lyte JM, Martin JA, Molinero-Perez A, Moloney G, Morelli E, Morillas E, O’Connor R, Cruz-Pereira JS, Peterson VL, Rea K, Ritz NL, Sherwin E, Spichak S, Teichman EM, van de Wouw M, Ventura-Silva AP, Wallace-Fitzsimons SE, Hyland N, Clarke G, Dinan TG (2019): The Microbiota-Gut-Brain Axis. Physiol Rev. 2019 Oct 1;99(4):1877-2013. doi: 10.1152/physrev.00018.2018. PMID: 31460832. REVIEW ↥ ↥ ↥ ↥ ↥ ↥ ↥
Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S (2011): Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3047-52. doi: 10.1073/pnas.1010529108. PMID: 21282636; PMCID: PMC3041077. ↥ ↥
Luczynski P, McVey Neufeld KA, Oriach CS, Clarke G, Dinan TG, Cryan JF (2016): Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior. Int J Neuropsychopharmacol. 2016 Aug 12;19(8):pyw020. doi: 10.1093/ijnp/pyw020. PMID: 26912607; PMCID: PMC5006193. REVIEW ↥ ↥
Li FJ, Zhang RY, Li JY, Liu YN, Zhang ZX, Du L, Li YD, Liu X, Zhang W, Cui GY, Xu CY (2024): Pain, obesity, adenosine salvage disruption, and smoking behavior mediate the effect of gut microbiota on sleep disorders: results from network Mendelian randomization and 16S rDNA sequencing. Front Microbiol. 2024 Jul 31;15:1413218. doi: 10.3389/fmicb.2024.1413218. PMID: 39144232; PMCID: PMC11322093. ↥
Huang Y, Cao J, Zhu M, Wang Z, Jin Z, Xiong Z (2024): Bacteroides fragilis aggravates high-fat diet-induced non-alcoholic fatty liver disease by regulating lipid metabolism and remodeling gut microbiota. Microbiol Spectr. 2024 Apr 2;12(4):e0339323. doi: 10.1128/spectrum.03393-23. PMID: 38411057; PMCID: PMC10986510. ↥
He B, Hoang TK, Tian X, Taylor CM, Blanchard E, Luo M, Bhattacharjee MB, Freeborn J, Park S, Couturier J, Lindsey JW, Tran DQ, Rhoads JM, Liu Y (2019): Lactobacillus reuteri Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Mice by Modulating Gut Microbiota. Front Immunol. 2019 Mar 7;10:385. doi: 10.3389/fimmu.2019.00385. PMID: 30899262; PMCID: PMC6416370. ↥ ↥ ↥
Montgomery TL, Künstner A, Kennedy JJ, Fang Q, Asarian L, Culp-Hill R, D’Alessandro A, Teuscher C, Busch H, Krementsov DN (2020): Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity. Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27516-27527. doi: 10.1073/pnas.2002817117. PMID: 33077601; PMCID: PMC7959502. ↥ ↥
Li W, Dowd SE, Scurlock B, Acosta-Martinez V, Lyte M (2009): Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav. 2009 Mar 23;96(4-5):557-67. doi: 10.1016/j.physbeh.2008.12.004. PMID: 19135464. ↥
Forsythe P, Kunze W, Bienenstock J (2016): Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis? BMC Med. 2016 Apr 19;14:58. doi: 10.1186/s12916-016-0604-8. PMID: 27090095; PMCID: PMC4836158. ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY (2015): Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015 Apr 9;161(2):264-76. doi: 10.1016/j.cell.2015.02.047. Erratum in: Cell. 2015 Sep 24;163:258. PMID: 25860609; PMCID: PMC4393509. ↥
Kwak MJ, Kim SH, Kim HH, Tanpure R, Kim JI, Jeon BH, Park HK (2023): Psychobiotics and fecal microbial transplantation for autism and attention-deficit/hyperactivity disorder: microbiome modulation and therapeutic mechanisms. Front Cell Infect Microbiol. 2023 Jul 24;13:1238005. doi: 10.3389/fcimb.2023.1238005. PMID: 37554355; PMCID: PMC10405178. REVIEW ↥ ↥ ↥ ↥ ↥ ↥ ↥
Haas-Neill S, Forsythe P (2020): A Budding Relationship: Bacterial Extracellular Vesicles in the Microbiota-Gut-Brain Axis. Int J Mol Sci. 2020 Nov 24;21(23):8899. doi: 10.3390/ijms21238899. PMID: 33255332; PMCID: PMC7727686. REVIEW ↥ ↥ ↥ ↥
Perez-Burgos A, Mao YK, Bienenstock J, Kunze WA (2014): The gut-brain axis rewired: adding a functional vagal nicotinic “sensory synapse”. FASEB J. 2014 Jul;28(7):3064-74. doi: 10.1096/fj.13-245282. PMID: 24719355. ↥
Liu B, Wanders A, Wirdefeldt K, Sjölander A, Sachs MC, Eberhardson M, Ye W, Ekbom A, Olén O, Ludvigsson JF (2020): Vagotomy and subsequent risk of inflammatory bowel disease: a nationwide register-based matched cohort study. Aliment Pharmacol Ther. 2020 Jun;51(11):1022-1030. doi: 10.1111/apt.15715. PMID: 32319125. ↥
Zou Q, Han S, Liang J, Yan G, Wang Q, Wang Y, Zhang Z, Hu J, Li J, Yuan T, Liu Z (2024): Alleviating effect of vagus nerve cutting in Salmonella-induced gut infections and anxiety-like behavior via enhancing microbiota-derived GABA. Brain Behav Immun. 2024 Jul;119:607-620. doi: 10.1016/j.bbi.2024.04.034. PMID: 38663772. ↥
Cordella F, Sanchini C, Rosito M, Ferrucci L, Pediconi N, Cortese B, Guerrieri F, Pascucci GR, Antonangeli F, Peruzzi G, Giubettini M, Basilico B, Pagani F, Grimaldi A, D’Alessandro G, Limatola C, Ragozzino D, Di Angelantonio S (2021): Antibiotics Treatment Modulates Microglia-Synapses Interaction. Cells. 2021 Oct 4;10(10):2648. doi: 10.3390/cells10102648. PMID: 34685628; PMCID: PMC8534187. ↥
Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P, Macri J, McCoy KD, Verdu EF, Collins SM (2011): The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology. 2011 Aug;141(2):599-609, 609.e1-3. doi: 10.1053/j.gastro.2011.04.052. PMID: 21683077. ↥
Desbonnet L, Clarke G, Traplin A, O’Sullivan O, Crispie F, Moloney RD, Cotter PD, Dinan TG, Cryan JF (2015): Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour. Brain Behav Immun. 2015 Aug;48:165-73. doi: 10.1016/j.bbi.2015.04.004. PMID: 25866195. ↥
O’Mahony SM, Felice VD, Nally K, Savignac HM, Claesson MJ, Scully P, Woznicki J, Hyland NP, Shanahan F, Quigley EM, Marchesi JR, O’Toole PW, Dinan TG, Cryan JF (2014): Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats. Neuroscience. 2014 Sep 26;277:885-901. doi: 10.1016/j.neuroscience.2014.07.054. PMID: 25088912. ↥
Xu D, Gao J, Gillilland M 3rd, Wu X, Song I, Kao JY, Owyang C (2014): Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats. Gastroenterology. 2014 Feb;146(2):484-96.e4. doi: 10.1053/j.gastro.2013.10.026. PMID: 24161699; PMCID: PMC3939606. ↥ ↥
Jakobi B, Cimetti C, Mulder D, Vlaming P, Franke B, Hoogman M, Arias-Vasquez A (2024): The Role of Diet and the Gut Microbiota in Reactive Aggression and Adult ADHD-An Exploratory Analysis. Nutrients. 2024 Jul 9;16(14):2174. doi: 10.3390/nu16142174. PMID: 39064617; PMCID: PMC11279949. ↥
Bull-Larsen, Mohajeri (2019): The Potential Influence of the Bacterial Microbiome on the Development and Progression of ADHD. Nutrients. 2019 Nov 17;11(11). pii: E2805. doi: 10.3390/nu11112805. REVIEW ↥ ↥
Fristedt R, Ruppert V, Trower T, Cooney J, Landberg R (2024): Quantitation of circulating short-chain fatty acids in small volume blood samples from animals and humans. Talanta. 2024 May 15;272:125743. doi: 10.1016/j.talanta.2024.125743. PMID: 38382298. ↥ ↥
van de Wouw M, Boehme M, Lyte JM, Wiley N, Strain C, O’Sullivan O, Clarke G, Stanton C, Dinan TG, Cryan JF (2018): Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations. J Physiol. 2018 Oct;596(20):4923-4944. doi: 10.1113/JP276431. PMID: 30066368; PMCID: PMC6187046. ↥
Janik, Thomason, Stanisz, Forsythe, Bienenstock, Stanisz (2016): Magnetic resonance spectroscopy reveals oral Lactobacillus promotion of increases in brain GABA, N-acetyl aspartate and glutamate. Neuroimage. 2016 Jan 15;125:988-995. doi: 10.1016/j.neuroimage.2015.11.018. ↥
Demaude J, Salvador-Cartier C, Fioramonti J, Ferrier L, Bueno L (2006): Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction. Gut. 2006 May;55(5):655-61. doi: 10.1136/gut.2005.078675. PMID: 16299034; PMCID: PMC1856132. ↥
Sudo N (2014): Microbiome, HPA axis and production of endocrine hormones in the gut. Adv Exp Med Biol. 2014;817:177-94. doi: 10.1007/978-1-4939-0897-4_8. PMID: 24997034. ↥
De Palma G, Blennerhassett P, Lu J, Deng Y, Park AJ, Green W, Denou E, Silva MA, Santacruz A, Sanz Y, Surette MG, Verdu EF, Collins SM, Bercik P (2015): Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nat Commun. 2015 Jul 28;6:7735. doi: 10.1038/ncomms8735. PMID: 26218677. ↥
Strandwitz P (2018): Neurotransmitter modulation by the gut microbiota. Brain Res. 2018 Aug 15;1693(Pt B):128-133. doi: 10.1016/j.brainres.2018.03.015. PMID: 29903615; PMCID: PMC6005194. REVIEW ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Erny D, Hrabě de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, Schwierzeck V, Utermöhlen O, Chun E, Garrett WS, McCoy KD, Diefenbach A, Staeheli P, Stecher B, Amit I, Prinz M (2015): Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015 Jul;18(7):965-77. doi: 10.1038/nn.4030. PMID: 26030851; PMCID: PMC5528863. ↥
Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, Korecka A, Bakocevic N, Ng LG, Kundu P, Gulyás B, Halldin C, Hultenby K, Nilsson H, Hebert H, Volpe BT, Diamond B, Pettersson S (2014): The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014 Nov 19;6(263):263ra158. doi: 10.1126/scitranslmed.3009759. Erratum in: Sci Transl Med. 2014 Dec 10;6(266):266er7. Guan, Ng Lai [corrected to Ng, Lai Guan]. PMID: 25411471; PMCID: PMC4396848. ↥
Thomas CM, Hong T, van Pijkeren JP, Hemarajata P, Trinh DV, Hu W, Britton RA, Kalkum M, Versalovic J (2012): Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One. 2012;7(2):e31951. doi: 10.1371/journal.pone.0031951. PMID: 22384111; PMCID: PMC3285189. ↥
Galland L. The gut microbiome and the brain (2014): J Med Food. 2014 Dec;17(12):1261-72. doi: 10.1089/jmf.2014.7000. PMID: 25402818; PMCID: PMC4259177. REVIEW ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Lyte M (2011): Probiotics function mechanistically as delivery vehicles for neuroactive compounds: Microbial endocrinology in the design and use of probiotics. Bioessays. 2011 Aug;33(8):574-81. doi: 10.1002/bies.201100024. PMID: 21732396. ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Maini Rekdal V, Bess EN, Bisanz JE, Turnbaugh PJ, Balskus EP (2019): Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science. 2019 Jun 14;364(6445):eaau6323. doi: 10.1126/science.aau6323. PMID: 31196984; PMCID: PMC7745125. ↥ ↥ ↥
O’Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF (2015): Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2015 Jan 15;277:32-48. doi: 10.1016/j.bbr.2014.07.027. PMID: 25078296. REVIEW ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF (2011): Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16050-5. doi: 10.1073/pnas.1102999108. PMID: 21876150; PMCID: PMC3179073. ↥ ↥ ↥ ↥ ↥
Macia L, Nanan R, Hosseini-Beheshti E, Grau GE (2019): Host- and Microbiota-Derived Extracellular Vesicles, Immune Function, and Disease Development. Int J Mol Sci. 2019 Dec 22;21(1):107. doi: 10.3390/ijms21010107. PMID: 31877909; PMCID: PMC6982009. REVIEW ↥
Lee EY, Bang JY, Park GW, Choi DS, Kang JS, Kim HJ, Park KS, Lee JO, Kim YK, Kwon KH, Kim KP, Gho YS (2007): Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. Proteomics. 2007 Sep;7(17):3143-53. doi: 10.1002/pmic.200700196. Erratum in: Proteomics. 2007 Oct;7(20):3821. PMID: 17787032. ↥
Yaghoubfar R, Behrouzi A, Ashrafian F, Shahryari A, Moradi HR, Choopani S, Hadifar S, Vaziri F, Nojoumi SA, Fateh A, Khatami S, Siadat SD (2020): Modulation of serotonin signaling/metabolism by Akkermansia muciniphila and its extracellular vesicles through the gut-brain axis in mice. Sci Rep. 2020 Dec 17;10(1):22119. doi: 10.1038/s41598-020-79171-8. PMID: 33335202; PMCID: PMC7747642. ↥ ↥
Chelakkot C, Choi Y, Kim DK, Park HT, Ghim J, Kwon Y, Jeon J, Kim MS, Jee YK, Gho YS, Park HS, Kim YK, Ryu SH (2018): Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp Mol Med. 2018 Feb 23;50(2):e450. doi: 10.1038/emm.2017.282. PMID: 29472701; PMCID: PMC5903829. ↥
Jones EJ, Booth C, Fonseca S, Parker A, Cross K, Miquel-Clopés A, Hautefort I, Mayer U, Wileman T, Stentz R, Carding SR (2020): The Uptake, Trafficking, and Biodistribution of Bacteroides thetaiotaomicron Generated Outer Membrane Vesicles. Front Microbiol. 2020 Feb 6;11:57. doi: 10.3389/fmicb.2020.00057. PMID: 32117106; PMCID: PMC7015872. ↥
Jang SC, Kim SR, Yoon YJ, Park KS, Kim JH, Lee J, Kim OY, Choi EJ, Kim DK, Choi DS, Kim YK, Park J, Di Vizio D, Gho YS (2015): In vivo kinetic biodistribution of nano-sized outer membrane vesicles derived from bacteria. Small. 2015 Jan 27;11(4):456-61. doi: 10.1002/smll.201401803. PMID: 25196673. ↥
Han EC, Choi SY, Lee Y, Park JW, Hong SH, Lee HJ (2019): Extracellular RNAs in periodontopathogenic outer membrane vesicles promote TNF-α production in human macrophages and cross the blood-brain barrier in mice. FASEB J. 2019 Dec;33(12):13412-13422. doi: 10.1096/fj.201901575R. PMID: 31545910; PMCID: PMC6894046. ↥
Kang CS, Ban M, Choi EJ, Moon HG, Jeon JS, Kim DK, Park SK, Jeon SG, Roh TY, Myung SJ, Gho YS, Kim JG, Kim YK (2013): Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS One. 2013 Oct 24;8(10):e76520. doi: 10.1371/journal.pone.0076520. PMID: 24204633; PMCID: PMC3811976. ↥
Reichert (2024) Zelluläre Interaktion - Untersuchungen zur inter- und intraspezies Kommunikation durch Extrazelluläre Vesikel, Dissertation german ↥
Dahlqvist A, Hellström S, Carlsöö B, Pequignot JM (1987): Paraganglia of the rat recurrent laryngeal nerve after long-term hypoxia: a morphometric and biochemical study. J Neurocytol. 1987 Jun;16(3):289-97. doi: 10.1007/BF01611341. PMID: 3612181. ↥
Wang X, Cui X, Wu J, Bao L, Tan Z, Chen C (2023): Peripheral nerves directly mediate the transneuronal translocation of silver nanomaterials from the gut to central nervous system. Sci Adv. 2023 Jul 7;9(27):eadg2252. doi: 10.1126/sciadv.adg2252. PMID: 37418525; PMCID: PMC10328400. ↥
Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM, Mazmanian SK, Volpicelli-Daley LA, Gradinaru V (2020): Gut-seeded α-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci. 2020 Mar;23(3):327-336. doi: 10.1038/s41593-020-0589-7. PMID: 32066981; PMCID: PMC7065967. ↥
Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF, Ekbom A, Svenningsson P, Chen H, Wirdefeldt K (2017): Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study. Neurology. 2017 May 23;88(21):1996-2002. doi: 10.1212/WNL.0000000000003961. PMID: 28446653; PMCID: PMC5440238. ↥
Svensson E, Horváth-Puhó E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, Sørensen HT (2015): Vagotomy and subsequent risk of Parkinson’s disease. Ann Neurol. 2015 Oct;78(4):522-9. doi: 10.1002/ana.24448. PMID: 26031848. ↥
Aarts, Ederveen, Naaijen, Zwiers, Boekhorst, Timmerman, Smeekens, Netea, Buitelaar, Franke, van Hijum, Arias Vasquez (2017): Gut microbiome in ADHD and its relation to neural reward anticipation. PLoS One. 2017 Sep 1;12(9):e0183509. doi: 10.1371/journal.pone.0183509. PMID: 28863139; PMCID: PMC5581161. ↥ ↥ ↥ ↥ ↥
Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C, Koga Y (2004): Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004 Jul 1;558(Pt 1):263-75. doi: 10.1113/jphysiol.2004.063388. PMID: 15133062; PMCID: PMC1664925. ↥
Bonaz B, Bazin T, Pellissier S (2018): The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. Front Neurosci. 2018 Feb 7;12:49. doi: 10.3389/fnins.2018.00049. PMID: 29467611; PMCID: PMC5808284. REVIEW ↥
Borrego-Ruiz A, Borrego JJ (2024): Neurodevelopmental Disorders Associated with Gut Microbiome Dysbiosis in Children. Children (Basel). 2024 Jun 28;11(7):796. doi: 10.3390/children11070796. PMID: 39062245; PMCID: PMC11275248. REVIEW ↥ ↥ ↥ ↥
Thomas SP, Denu JM (2021): Short-chain fatty acids activate acetyltransferase p300. Elife. 2021 Oct 22;10:e72171. doi: 10.7554/eLife.72171. PMID: 34677127; PMCID: PMC8585482. ↥
Ntorla A, Burgoyne JR (2021): The Regulation and Function of Histone Crotonylation. Front Cell Dev Biol. 2021 Apr 6;9:624914. doi: 10.3389/fcell.2021.624914. PMID: 33889571; PMCID: PMC8055951. REVIEW ↥
Fellows R, Denizot J, Stellato C, Cuomo A, Jain P, Stoyanova E, Balázsi S, Hajnády Z, Liebert A, Kazakevych J, Blackburn H, Corrêa RO, Fachi JL, Sato FT, Ribeiro WR, Ferreira CM, Perée H, Spagnuolo M, Mattiuz R, Matolcsi C, Guedes J, Clark J, Veldhoen M, Bonaldi T, Vinolo MAR, Varga-Weisz P (2018): Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases. Nat Commun. 2018 Jan 9;9(1):105. doi: 10.1038/s41467-017-02651-5. PMID: 29317660; PMCID: PMC5760624. ↥
Gates LA, Reis BS, Lund PJ, Paul MR, Leboeuf M, Djomo AM, Nadeem Z, Lopes M, Vitorino FN, Unlu G, Carroll TS, Birsoy K, Garcia BA, Mucida D, Allis CD (2024): Histone butyrylation in the mouse intestine is mediated by the microbiota and associated with regulation of gene expression. Nat Metab. 2024 Apr;6(4):697-707. doi: 10.1038/s42255-024-00992-2. PMID: 38413806; PMCID: PMC11520355. ↥
D’Alessandro G, Marrocco F, Limatola C (2022): Microglial cells: Sensors for neuronal activity and microbiota-derived molecules. Front Immunol. 2022 Nov 8;13:1011129. doi: 10.3389/fimmu.2022.1011129. PMID: 36426369; PMCID: PMC9679421. REVIEW ↥
Spichak S, Donoso F, Moloney GM, Gunnigle E, Brown JM, Codagnone M, Dinan TG, Cryan JF (2021): Microbially-derived short-chain fatty acids impact astrocyte gene expression in a sex-specific manner. Brain Behav Immun Health. 2021 Aug 6;16:100318. doi: 10.1016/j.bbih.2021.100318. PMID: 34589808; PMCID: PMC8474187. ↥
Clare CE, Brassington AH, Kwong WY, Sinclair KD (2019): One-Carbon Metabolism: Linking Nutritional Biochemistry to Epigenetic Programming of Long-Term Development. Annu Rev Anim Biosci. 2019 Feb 15;7:263-287. doi: 10.1146/annurev-animal-020518-115206. PMID: 30412672. REVIEW ↥
Wang L, Xie Z, Li G, Li G, Liang J (2023): Two-sample Mendelian randomization analysis investigates causal associations between gut microbiota and attention deficit hyperactivity disorder. Front Microbiol. 2023 Apr 24;14:1144851. doi: 10.3389/fmicb.2023.1144851. PMID: 37168108; PMCID: PMC10166206. ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Tengeler, Dam, Wiesmann, Naaijen, van Bodegom, Belzer, Dederen, Verweij, Franke, Kozicz, Arias Vasquez, Kiliaan (2020): Gut microbiota from persons with attention-deficit/hyperactivity disorder affects the brain in mice. Microbiome. 2020 Apr 1;8(1):44. doi: 10.1186/s40168-020-00816-x. PMID: 32238191; PMCID: PMC7114819. ↥ ↥ ↥
Hooi, Dwiyanto, Rasiti, Toh, Wong RKM, Lee JWJ (2022): A case report of improvement on ADHD symptoms after fecal microbiota transplantation with gut microbiome profiling pre- and post-procedure. Curr Med Res Opin. 2022 Sep 26:1-13. doi: 10.1080/03007995.2022.2129232. PMID: 36164761. ↥
Swann JR, Diaz Heijtz R, Mayneris-Perxachs J, Arora A, Isaksson J, Bölte S, Tammimies K (2023): Characterizing the metabolomic signature of attention-deficit hyperactivity disorder in twins. Neuropharmacology. 2023 Apr 24:109562. doi: 10.1016/j.neuropharm.2023.109562. PMID: 37100381. ↥
Jadhav KS, Peterson VL, Halfon O, Ahern G, Fouhy F, Stanton C, Dinan TG, Cryan JF, Boutrel B (2018): Gut microbiome correlates with altered striatal dopamine receptor expression in a model of compulsive alcohol seeking. Neuropharmacology. 2018 Oct;141:249-259. doi: 10.1016/j.neuropharm.2018.08.026. PMID: 30172845. ↥
He Y, Zhao J, Ma Y, Yan X, Duan Y, Zhang X, Dong H, Fang R, Zhang Y, Li Q, Yang P, Yu M, Fei J, Huang F (2024): Citrobacter rodentium infection impairs dopamine metabolism and exacerbates the pathology of Parkinson’s disease in mice. J Neuroinflammation. 2024 Jun 7;21(1):153. doi: 10.1186/s12974-024-03145-0. PMID: 38849869; PMCID: PMC11161935. ↥
Yang LL, Stiernborg M, Skott E, Gillberg T, Landberg R, Giacobini M, Lavebratt C (2022): Lower plasma concentrations of short-chain fatty acids (SCFAs) in patients with ADHD. J Psychiatr Res. 2022 Sep 28;156:36-43. doi: 10.1016/j.jpsychires.2022.09.042. PMID: 36228390. n = 269 ↥
Yang LL, Stiernborg M, Skott E, Xu J, Wu Y, Landberg R, Arefin S, Kublickiene K, Millischer V, Nilsson IAK, Schalling M, Giacobini M, Lavebratt C (2023): Effects of a Synbiotic on Plasma Immune Activity Markers and Short-Chain Fatty Acids in Children and Adults with ADHD-A Randomized Controlled Trial. Nutrients. 2023 Mar 6;15(5):1293. doi: 10.3390/nu15051293. PMID: 36904292; PMCID: PMC10004766. ↥
Di Gesù CM, Buffington SA (2024): The early life exposome and autism risk: a role for the maternal microbiome? Gut Microbes. 2024 Jan-Dec;16(1):2385117. doi: 10.1080/19490976.2024.2385117. PMID: 39120056; PMCID: PMC11318715. REVIEW ↥
Eicher, Mohajeri (2022): Overlapping Mechanisms of Action of Brain-Active Bacteria and Bacterial Metabolites in the Pathogenesis of Common Brain Diseases. Nutrients. 2022 Jun 27;14(13):2661. doi: 10.3390/nu14132661. PMID: 35807841. ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Borre, O’Keeffe, Clarke, Stanton, Dinan, Cryan (2020): Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med. 2014 Sep;20(9):509-18. doi: 10.1016/j.molmed.2014.05.002. PMID: 24956966. REVIEW ↥
Pärtty A, Kalliomäki M, Wacklin P, Salminen S, Isolauri E (2015): A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatr Res. 2015 Jun;77(6):823-8. doi: 10.1038/pr.2015.51. PMID: 25760553., n = 75 ↥ ↥
Vasiliu O (2023) The current state of research for psychobiotics use in the management of psychiatric disorders-A systematic literature review. Front Psychiatry. 2023 Feb 23;14:1074736. doi: 10.3389/fpsyt.2023.1074736. PMID: 36911130; PMCID: PMC9996157. REVIEW ↥
Li Y, Sun H, Huang Y, Yin A, Zhang L, Han J, Lyu Y, Xu X, Zhai Y, Sun H, Wang P, Zhao J, Sun S, Dong H, Zhu F, Wang Q, Augusto Rohde L, Xie X, Sun X, Xiong L (2022): Gut metagenomic characteristics of ADHD reveal low Bacteroides ovatus-associated host cognitive impairment. Gut Microbes. 2022 Jan-Dec;14(1):2125747. doi: 10.1080/19490976.2022.2125747. PMID: 36128620; PMCID: PMC9519028. ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Borrego-Ruiz A, Borrego JJ (2024): An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jan 10;128:110861. doi: 10.1016/j.pnpbp.2023.110861. PMID: 37690584. REVIEW ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Wang, Yang, Chou, Lee, Chou, Kuo, Yeh, Lee, Huang, Li (2019): Gut microbiota and dietary patterns in children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2019 May 22. doi: 10.1007/s00787-019-01352-2. ↥ ↥ ↥ ↥ ↥
Jakobi B, Vlaming P, Mulder D, Ribases M, Richarte V, Ramos-Quiroga JA, Tendolkar I, van Eijndhoven P, Vrijsen JN, Buitelaar J, Franke B, Hoogman M, Bloemendaal M, Arias-Vasquez A (2024): The gut-microbiome in adult Attention-deficit/hyperactivity disorder - A Meta-analysis. Eur Neuropsychopharmacol. 2024 Nov;88:21-29. doi: 10.1016/j.euroneuro.2024.07.004. PMID: 39121711. METASTUDY ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Sukmajaya AC, Lusida MI, Soetjipto, Setiawati Y (2021): Systematic review of gut microbiota and attention-deficit hyperactivity disorder (ADHD). Ann Gen Psychiatry. 2021 Feb 16;20(1):12. doi: 10.1186/s12991-021-00330-w. PMID: 33593384; PMCID: PMC7888126. REVIEW ↥
Panpetch J, Kiatrungrit K, Tuntipopipat S, Tangphatsornruang S, Mhuantong W, Chongviriyaphan N (2024): Gut Microbiota and Clinical Manifestations in Thai Pediatric Patients with Attention-Deficit Hyperactivity Disorder. J Pers Med. 2024 Jul 10;14(7):739. doi: 10.3390/jpm14070739. PMID: 39063993; PMCID: PMC11277806. ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Wan L, Ge WR, Zhang S, Sun YL, Wang B, Yang G (2020): Case-Control Study of the Effects of Gut Microbiota Composition on Neurotransmitter Metabolic Pathways in Children With Attention Deficit Hyperactivity Disorder. Front Neurosci. 2020 Feb 18;14:127. doi: 10.3389/fnins.2020.00127. PMID: 32132899; PMCID: PMC7040164. ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Jiang, Zhou, Zhou, Li, Yuan, Li, Ruan (2018): Gut microbiota profiles in treatment-naïve children with attention deficit hyperactivity disorder. Behav Brain Res. 2018 Jul 16;347:408-413. doi: 10.1016/j.bbr.2018.03.036. PMID: 29580894. n = 83 ↥ ↥ ↥
Gkougka, Mitropoulos, Tzanakaki, Panagouli, Psaltopoulou, Thomaidis, Tsolia, Sergentanis, Tsitsika (2022): Gut microbiome and attention deficit/hyperactivity disorder: a systematic review. Pediatr Res. 2022 Mar 30. doi: 10.1038/s41390-022-02027-6. PMID: 35354932. METASTUDIE ↥ ↥ ↥
Caputi V, Hill L, Figueiredo M, Popov J, Hartung E, Margolis KG, Baskaran K, Joharapurkar P, Moshkovich M, Pai N (2024): Functional contribution of the intestinal microbiome in autism spectrum disorder, attention deficit hyperactivity disorder, and Rett syndrome: a systematic review of pediatric and adult studies. Front Neurosci. 2024 Mar 7;18:1341656. doi: 10.3389/fnins.2024.1341656. PMID: 38516317; PMCID: PMC10954784. METASTUDY ↥ ↥
Wan, Ge, Zhang, Sun, Wang, Yang (2020): Case-Control Study of the Effects of Gut Microbiota Composition on Neurotransmitter Metabolic Pathways in Children With Attention Deficit Hyperactivity Disorder. Front Neurosci. 2020 Feb 18;14:127. doi: 10.3389/fnins.2020.00127. PMID: 32132899; PMCID: PMC7040164. ↥ ↥ ↥ ↥
Prehn-Kristensen A, Zimmermann A, Tittmann L, Lieb W, Schreiber S, Baving L, Fischer A (2018): Reduced microbiome alpha diversity in young patients with ADHD. PLoS One. 2018 Jul 12;13(7):e0200728. doi: 10.1371/journal.pone.0200728. PMID: 30001426; PMCID: PMC6042771. ↥
Szopinska-Tokov J, Dam S, Naaijen J, Konstanti P, Rommelse N, Belzer C, Buitelaar J, Franke B, Bloemendaal M, Aarts E, Arias Vasquez A (2020): Correction: Szopinska-Tokov et al. Investigating the Gut Microbiota Composition of Individuals with Attention-Deficit/Hyperactivity Disorder and Association with Symptoms. Microorganisms 2020, 8, 406. Microorganisms. 2021 Jun 23;9(7):1358. doi: 10.3390/microorganisms9071358. Erratum for: Microorganisms. 2020 Mar 13;8(3): PMID: 34201905; PMCID: PMC8306196. ↥
Szopinska-Tokov J, Dam S, Naaijen J, Konstanti P, Rommelse N, Belzer C, Buitelaar J, Franke B, Aarts E, Arias Vasquez A (2020): Investigating the Gut Microbiota Composition of Individuals with Attention-Deficit/Hyperactivity Disorder and Association with Symptoms. Microorganisms. 2020 Mar 13;8(3):406. doi: 10.3390/microorganisms8030406. Erratum in: Microorganisms. 2021 Jun 23;9(7):1358. doi: 10.3390/microorganisms9071358. PMID: 32183143; PMCID: PMC7143990. ↥ ↥ ↥ ↥
Lee MJ, Lai HC, Kuo YL, Chen VC (2022): Association between Gut Microbiota and Emotional-Behavioral Symptoms in Children with Attention-Deficit/Hyperactivity Disorder. J Pers Med. 2022 Oct 2;12(10):1634. doi: 10.3390/jpm12101634. PMID: 36294773; PMCID: PMC9605220. ↥ ↥ ↥ ↥ ↥ ↥ ↥
Taş E, Ülgen KO (2023): Understanding the ADHD-Gut Axis by Metabolic Network Analysis. Metabolites. 2023 Apr 26;13(5):592. doi: 10.3390/metabo13050592. PMID: 37233633; PMCID: PMC10223614. ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Prehn-Kristensen A, Zimmermann A, Tittmann L, Lieb W, Schreiber S, Baving L, Fischer A (2018): Reduced microbiome alpha diversity in young patients with ADHD. PLoS One. 2018 Jul 12;13(7):e0200728. doi: 10.1371/journal.pone.0200728. PMID: 30001426; PMCID: PMC6042771. ↥ ↥ ↥
Xiao L, Liu S, Wu Y, Huang Y, Tao S, Liu Y, Tang Y, Xie M, Ma Q, Yin Y, Dai M, Zhang M, Llamocca E, Gui H, Wang Q (2023): The interactions between host genome and gut microbiome increase the risk of psychiatric disorders: Mendelian randomization and biological annotation. Brain Behav Immun. 2023 Aug 8;113:389-400. doi: 10.1016/j.bbi.2023.08.003. PMID: 37557965. ↥ ↥ ↥
Eicher TP, Mohajeri MH (2022): Overlapping Mechanisms of Action of Brain-Active Bacteria and Bacterial Metabolites in the Pathogenesis of Common Brain Diseases. Nutrients. 2022 Jun 27;14(13):2661. doi: 10.3390/nu14132661. PMID: 35807841; PMCID: PMC9267981. ↥
Bergwerff CE, Luman M, Blom HJ, Oosterlaan J (2016): No Tryptophan, Tyrosine and Phenylalanine Abnormalities in Children with Attention-Deficit/Hyperactivity Disorder. PLoS One. 2016 Mar 3;11(3):e0151100. doi: 10.1371/journal.pone.0151100. PMID: 26938936; PMCID: PMC4777504. ↥
Cheng S, Han B, Ding M, Wen Y, Ma M, Zhang L, Qi X, Cheng B, Li P, Kafle OP, Liang X, Liu L, Du Y, Zhao Y, Zhang F (2020): Identifying psychiatric disorder-associated gut microbiota using microbiota-related gene set enrichment analysis. Brief Bioinform. 2020 May 21;21(3):1016-1022. doi: 10.1093/bib/bbz034. PMID: 30953055. ↥ ↥
Novau-Ferré N, Papandreou C, Rojo-Marticella M, Canals-Sans J, Bulló M (2025): Gut microbiome differences in children with Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder and effects of probiotic supplementation: A randomized controlled trial. Res Dev Disabil. 2025 Apr 3;161:105003. doi: 10.1016/j.ridd.2025.105003. PMID: 40184961. ↥ ↥ ↥
You M, Chen N, Yang Y, Cheng L, He H, Cai Y, Liu Y, Liu H, Hong G (2024): The gut microbiota-brain axis in neurological disorders. MedComm (2020). 2024 Jul 20;5(8):e656. doi: 10.1002/mco2.656. PMID: 39036341; PMCID: PMC11260174. REVIEW ↥ ↥
Steckler R, Magzal F, Kokot M, Walkowiak J, Tamir S (2024): Disrupted gut harmony in attention-deficit/hyperactivity disorder: Dysbiosis and decreased short-chain fatty acids. Brain Behav Immun Health. 2024 Jul 27;40:100829. doi: 10.1016/j.bbih.2024.100829. PMID: 39184374; PMCID: PMC11342906. n = 73 ↥
Wang LJ, Li SC, Li SW, Kuo HC, Lee SY, Huang LH, Chin CY, Yang CY (2022): Gut microbiota and plasma cytokine levels in patients with attention-deficit/hyperactivity disorder. Transl Psychiatry. 2022 Feb 23;12(1):76. doi: 10.1038/s41398-022-01844-x. PMID: 35197458; PMCID: PMC8866486. ↥ ↥
Steckler R, Magzal F, Kokot M, Walkowiak J, Tamir S (2024): Disrupted gut harmony in attention-deficit/hyperactivity disorder: Dysbiosis and decreased short-chain fatty acids. Brain Behav Immun Health. 2024 Jul 27;40:100829. doi: 10.1016/j.bbih.2024.100829. PMID: 39184374; PMCID: PMC11342906. ↥
Bundgaard-Nielsen C, Lauritsen MB, Knudsen JK, Rold LS, Larsen MH, Hindersson P, Villadsen AB, Leutscher PDC, Hagstrøm S, Nyegaard M, Sørensen S (2023): Children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorder share distinct microbiota compositions. Gut Microbes. 2023 Jan-Dec;15(1):2211923. doi: 10.1080/19490976.2023.2211923. PMID: 37199526; PMCID: PMC10197996. ↥
Sharon G, Cruz NJ, Kang DW, Gandal MJ, Wang B, Kim YM, Zink EM, Casey CP, Taylor BC, Lane CJ, Bramer LM, Isern NG, Hoyt DW, Noecker C, Sweredoski MJ, Moradian A, Borenstein E, Jansson JK, Knight R, Metz TO, Lois C, Geschwind DH, Krajmalnik-Brown R, Mazmanian SK (2019): Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice. Cell. 2019 May 30;177(6):1600-1618.e17. doi: 10.1016/j.cell.2019.05.004. PMID: 31150625; PMCID: PMC6993574. ↥ ↥
Cho YJ, Shin B, Lee SH, Park S, Kim YK, Kim JJ, Kim E (2023): Altered Urine Microbiome in Male Children and Adolescents with Attention-Deficit Hyperactivity Disorder. Microorganisms. 2023 Aug 11;11(8):2063. doi: 10.3390/microorganisms11082063. PMID: 37630623; PMCID: PMC10458914. ↥
Chudzik A, Słowik T, Kochalska K, Pankowska A, Łazorczyk A, Andres-Mach M, Rola R, Stanisz GJ, Orzyłowska A (2022): Continuous Ingestion of Lacticaseibacillus rhamnosus JB-1 during Chronic Stress Ensures Neurometabolic and Behavioural Stability in Rats. Int J Mol Sci. 2022 May 5;23(9):5173. doi: 10.3390/ijms23095173. PMID: 35563564; PMCID: PMC9106030. ↥
Schroeder FA, Lin CL, Crusio WE, Akbarian S (2007): Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry. 2007 Jul 1;62(1):55-64. doi: 10.1016/j.biopsych.2006.06.036. PMID: 16945350. ↥
Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, Bisson JF, Rougeot C, Pichelin M, Cazaubiel M, Cazaubiel JM (2011): Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011 Mar;105(5):755-64. doi: 10.1017/S0007114510004319. PMID: 20974015. ↥
Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM, Logan AC (2009): A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 2009 Mar 19;1(1):6. doi: 10.1186/1757-4749-1-6. PMID: 19338686; PMCID: PMC2664325. ↥
Burokas A, Arboleya S, Moloney RD, Peterson VL, Murphy K, Clarke G, Stanton C, Dinan TG, Cryan JF (2017): Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice. Biol Psychiatry. 2017 Oct 1;82(7):472-487. doi: 10.1016/j.biopsych.2016.12.031. PMID: 28242013. ↥
Sgritta M, Dooling SW, Buffington SA, Momin EN, Francis MB, Britton RA, Costa-Mattioli M (2019): Mechanisms Underlying Microbial-Mediated Changes in Social Behavior in Mouse Models of Autism Spectrum Disorder. Neuron. 2019 Jan 16;101(2):246-259.e6. doi: 10.1016/j.neuron.2018.11.018. PMID: 30522820; PMCID: PMC6645363. ↥ ↥ ↥ ↥ ↥ ↥
Buffington SA, Di Prisco GV, Auchtung TA, Ajami NJ, Petrosino JF, Costa-Mattioli M (2016): Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring. Cell. 2016 Jun 16;165(7):1762-1775. doi: 10.1016/j.cell.2016.06.001. PMID: 27315483; PMCID: PMC5102250. ↥ ↥
Poutahidis T, Kearney SM, Levkovich T, Qi P, Varian BJ, Lakritz JR, Ibrahim YM, Chatzigiagkos A, Alm EJ, Erdman SE (2013): Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PLoS One. 2013 Oct 30;8(10):e78898. doi: 10.1371/journal.pone.0078898. PMID: 24205344; PMCID: PMC3813596. ↥
Tabouy L, Getselter D, Ziv O, Karpuj M, Tabouy T, Lukic I, Maayouf R, Werbner N, Ben-Amram H, Nuriel-Ohayon M, Koren O, Elliott E (2018): Dysbiosis of microbiome and probiotic treatment in a genetic model of autism spectrum disorders. Brain Behav Immun. 2018 Oct;73:310-319. doi: 10.1016/j.bbi.2018.05.015. PMID: 29787855. ↥
Buffington SA, Dooling SW, Sgritta M, Noecker C, Murillo OD, Felice DF, Turnbaugh PJ, Costa-Mattioli M (2021): Dissecting the contribution of host genetics and the microbiome in complex behaviors. Cell. 2021 Apr 1;184(7):1740-1756.e16. doi: 10.1016/j.cell.2021.02.009. PMID: 33705688; PMCID: PMC8996745. ↥ ↥
Wang X, Hu R, Lin F, Yang T, Lu Y, Sun Z, Li T, Chen J (2024): Lactobacillus reuteri or Lactobacillus rhamnosus GG intervention facilitates gut barrier function, decreases corticosterone and ameliorates social behavior in LPS-exposed offspring. Food Res Int. 2024 Dec;197(Pt 1):115212. doi: 10.1016/j.foodres.2024.115212. PMID: 39593298. ↥
Mazzone L, Dooling SW, Volpe E, Uljarević M, Waters JL, Sabatini A, Arturi L, Abate R, Riccioni A, Siracusano M, Pereira M, Engstrand L, Cristofori F, Adduce D, Francavilla R, Costa-Mattioli M, Hardan AY (2024): Precision microbial intervention improves social behavior but not autism severity: A pilot double-blind randomized placebo-controlled trial. Cell Host Microbe. 2024 Jan 10;32(1):106-116.e6. doi: 10.1016/j.chom.2023.11.021. PMID: 38113884. ↥ ↥
Chen RJ, Lai KH, Lee CH, Lin HY, Lin CC, Chen CH, Chen W, Chen WY, Vo TTT, Lee IT (2024): Exploring the Link between Xerostomia and Oral Health in Mental Illness: Insights from Autism Spectrum Disorder, Depression, Bipolar Disorder, and Schizophrenia. Healthcare (Basel). 2024 Oct 11;12(20):2018. doi: 10.3390/healthcare12202018. PMID: 39451433; PMCID: PMC11507428. REVIEW ↥
Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK (2013): Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013 Dec 19;155(7):1451-63. doi: 10.1016/j.cell.2013.11.024. PMID: 24315484; PMCID: PMC3897394. ↥
Grimaldi, Gibson, Vulevic, Giallourou, Castro-Mejía, Hansen, Gibson, Nielsen, Costabile (2019): A prebiotic intervention study in children with autism spectrum disorders (ASDs). Microbiome. 2018 Aug 2;6(1):133. doi: 10.1186/s40168-018-0523-3. – Vorsicht – Untersuchung eines Markenprodukts ↥
Montgomery TL, Peipert D, Krementsov DN (2024): Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet. Immunol Rev. 2024 Aug;325(1):131-151. doi: 10.1111/imr.13343. PMID: 38717158; PMCID: PMC11338732. REVIEW ↥
Ohland CL, Kish L, Bell H, Thiesen A, Hotte N, Pankiv E, Madsen KL (2013): Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome. Psychoneuroendocrinology. 2013 Sep;38(9):1738-47. doi: 10.1016/j.psyneuen.2013.02.008. PMID: 23566632. ↥
Zegarra-Ruiz DF, El Beidaq A, Iñiguez AJ, Lubrano Di Ricco M, Manfredo Vieira S, Ruff WE, Mubiru D, Fine RL, Sterpka J, Greiling TM, Dehner C, Kriegel MA (2019): A Diet-Sensitive Commensal Lactobacillus Strain Mediates TLR7-Dependent Systemic Autoimmunity. Cell Host Microbe. 2019 Jan 9;25(1):113-127.e6. doi: 10.1016/j.chom.2018.11.009. PMID: 30581114; PMCID: PMC6377154. ↥